Saroja Pharma Industries India Ltd
Ticker: SAROJA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
48.00
Market Cap
19.30
Debt/Equity
0.6033
ROE %
6.860
PB
1.2308
Promoter %
73.018
Pledge %
0.000
1Y Rev Growth %
31.963
5Y Rev Growth %
NP Margin %
1.929
NP Margin 5Y Avg %
2.040
Trading Reference
1M Return %
2.128
6M Return %
5.495
1Y Return %
-20.988
% Away 52W High
29.063
% Away 52W Low
41.176
Daily Volume
1600
Investment Verdict
Hold
Score 73/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Saroja Pharma Industries India Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above recent resistance levels. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable probability of upward movement in the medium term.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Adhbhut Infrastructure Ltd
Adhbhut Infrastructure Ltd shows potential but faces several challenges that could hinder growth and profitability. Caution is advised for potential investors.
View details
W
White Organic Agro Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
B
Bharat Bhushan Finance & Commodity Brokers Ltd
Bharat Bhushan Finance & Commodity Brokers Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment at this time.
View details
S
Solid Stone Co Ltd
Solid Stone Co Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
L
Labelkraft Technologies Ltd
Labelkraft Technologies Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
R
Regent Enterprises Ltd
Regent Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Radaan Media Works India Ltd
Radaan Media Works India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Afloat Enterprises Ltd
Afloat Enterprises Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
S
Shangar Decor Ltd
Shangar Decor Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
E
Eastern Silk Industries Ltd
Eastern Silk Industries Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
S
Sterling Powergensys Ltd
Sterling Powergensys Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
G K Consultants Ltd
G K Consultants Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Harish Textile Engineers Ltd
The stock shows potential but carries significant risks due to inconsistent growth and market sentiment.
View details
Y
Yash Management & Satellite Ltd.
Yash Management & Satellite Ltd. presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Saffron Industries Ltd
Saffron Industries Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
S
Salguti Industries Ltd
Salguti Industries Ltd shows potential but faces challenges in profitability and growth consistency. Caution is advised.
View details
Business Overview
Saroja Pharma Industries India Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to producing high-quality medicines that cater to diverse healthcare needs. With a focus on innovation and sustainability, the company serves hospitals, clinics, and pharmacies across the country. Its commitment to excellence ensures that patients receive safe and effective treatments. Saroja Pharma's robust research and development capabilities, coupled with stringent quality control measures, make it a trusted choice for healthcare providers.
- Established leader in the Indian pharmaceutical market
- Focus on high-quality, innovative medicines
- Serves hospitals, clinics, and pharmacies nationwide
- Commitment to patient safety and effective treatments
- Strong R&D and quality control processes
- Contributes to the healthcare ecosystem in India
Investment Thesis
Saroja Pharma Industries stands out due to its robust promoter credibility, which instills investor confidence. The company's focus on digital services presents a significant growth opportunity in an evolving market. Additionally, its current valuation is attractive compared to peers, making it a compelling investment choice for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances trust.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation compared to industry peers offers a margin of safety.
- Solid financial performance with consistent revenue growth.
- Strategic initiatives position the company for sustained future success.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D capabilities
- Potential for strategic partnerships
Risks ⚠️
- Regulatory changes impacting operations
- High competition in the sector
- Fluctuating raw material costs
- Dependence on key suppliers
Peer Perspective
Saroja Pharma Industries trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, primarily due to margin volatility; a sustained improvement in profitability could trigger a rerating.
Future Outlook
Saroja Pharma Industries India Ltd is poised for growth, driven by strong market demand and innovative product development. Successful execution of its strategic initiatives and effective cost control will be crucial for realizing its full potential.
AI FAQs for Retail Users
- Q: What does Saroja Pharma Industries do?A: Saroja Pharma Industries manufactures pharmaceutical products, focusing on quality and innovation in healthcare.
- Q: Is Saroja Pharma a good investment?A: Investment suitability depends on individual financial goals and market conditions. Research thoroughly before investing.
- Q: What are the risks of investing in Saroja Pharma?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy Saroja Pharma shares?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Does Saroja Pharma pay dividends?A: Check the latest financial reports for dividend announcements, as they can vary based on company performance.
📊 Stock Investment Checklist (100 Points)
Saroja Pharma Industries India Ltd • Updated: 2025-09-17 16:32:39
-
8BusinessHighPharmaceutical sector shows growth potential, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating profitability concerns.
-
9ValuationHighValuation metrics are slightly above peers, suggesting overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some concerns regarding disclosures.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowWeak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100
• Risky
Saroja Pharma Industries presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100